The Biotron Limited(ASX: BIT) share price is up 6% to 25 cents....

The Biotron Limited(ASX: BIT) share price is up 6% to 25 cents. This gain means the drug development company’s shares have surged 150% since this time last week. The driver of this gain has been news that its BIT225-009 HIV-1 Phase 2 data will be presented at an upcoming event in the United States. Investors may believe that this event will bring Biotron onto the radar of pharmaceutical companies that are looking for potential acquisition targets. In its trials, the company’s BIT225 drug has had a unique effect in patients, over and above viral suppression seen with current antiretroviral drugs.